IL1B and neoplasm: Together, these findings indicate that there was high incidence of CCL2, CCL5, TNFα and IL-1β expression in the tumor cells in the three groups of cancer patients, and that the expression of TNFα and IL-1β was further elevated in the IDC-with-relapse group.